BCL-2/IgH polymerase chain reaction status at the end of induction treatment is not predictive for progression-free survival in relapsed/resistant follicular lymphoma: results of a prospective randomized EORTC 20981 phase III intergroup study.

M.H.J. van Oers; E. Tönnissen; M. van Glabbeke; L. Giurgea; J.H. Jansen; R. Klasa; R.E. Marcus; M. Wolf; E. Kimby; A. Vranovsky; H. Holte; A. Hagenbeek; B.A. van der Reijden

BCL-2/IgH polymerase chain reaction status at the end of induction treatment is not predictive for progression-free survival in relapsed/resistant follicular lymphoma: results of a prospective randomized EORTC 20981 phase III intergroup study.

Translated title of the contribution: BCL-2/IgH polymerase chain reaction status at the end of induction treatment is not predictive for progression-free survival in relapsed/resistant follicular lymphoma: results of a prospective randomized EORTC 20981 phase III intergroup study.

M.H.J. van Oers
, E. Tönnissen
, M. van Glabbeke
, L. Giurgea
, J.H. Jansen
, R. Klasa
, R.E. Marcus
, M. Wolf
, E. Kimby
, A. Vranovsky
, H. Holte
, A. Hagenbeek
, B.A. van der Reijden

Hematology/Van Creveldclinic

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	BCL-2/IgH polymerase chain reaction status at the end of induction treatment is not predictive for progression-free survival in relapsed/resistant follicular lymphoma: results of a prospective randomized EORTC 20981 phase III intergroup study.
Original language	Undefined/Unknown
Pages (from-to)	2246-2252
Number of pages	7
Journal	Journal of Clinical Oncology
Volume	28
Issue number	13
Publication status	Published - 2010

Cite this

van Oers, M. H. J., Tönnissen, E., van Glabbeke, M., Giurgea, L., Jansen, J. H., Klasa, R., Marcus, R. E., Wolf, M., Kimby, E., Vranovsky, A., Holte, H., Hagenbeek, A., & van der Reijden, B. A. (2010). BCL-2/IgH polymerase chain reaction status at the end of induction treatment is not predictive for progression-free survival in relapsed/resistant follicular lymphoma: results of a prospective randomized EORTC 20981 phase III intergroup study. Journal of Clinical Oncology, 28(13), 2246-2252.

van Oers, M.H.J. ; Tönnissen, E. ; van Glabbeke, M. et al. / BCL-2/IgH polymerase chain reaction status at the end of induction treatment is not predictive for progression-free survival in relapsed/resistant follicular lymphoma: results of a prospective randomized EORTC 20981 phase III intergroup study. In: Journal of Clinical Oncology. 2010 ; Vol. 28, No. 13. pp. 2246-2252.

@article{9b1d11ceda114e34abb8fdf6481f65d9,

title = "BCL-2/IgH polymerase chain reaction status at the end of induction treatment is not predictive for progression-free survival in relapsed/resistant follicular lymphoma: results of a prospective randomized EORTC 20981 phase III intergroup study.",

author = "\{van Oers\}, M.H.J. and E. T{\"o}nnissen and \{van Glabbeke\}, M. and L. Giurgea and J.H. Jansen and R. Klasa and R.E. Marcus and M. Wolf and E. Kimby and A. Vranovsky and H. Holte and A. Hagenbeek and \{van der Reijden\}, B.A.",

year = "2010",

language = "Undefined/Unknown",

volume = "28",

pages = "2246--2252",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "Lippincott Williams \& Wilkins",

number = "13",

}

van Oers, MHJ, Tönnissen, E, van Glabbeke, M, Giurgea, L, Jansen, JH, Klasa, R, Marcus, RE, Wolf, M, Kimby, E, Vranovsky, A, Holte, H, Hagenbeek, A & van der Reijden, BA 2010, 'BCL-2/IgH polymerase chain reaction status at the end of induction treatment is not predictive for progression-free survival in relapsed/resistant follicular lymphoma: results of a prospective randomized EORTC 20981 phase III intergroup study.', Journal of Clinical Oncology, vol. 28, no. 13, pp. 2246-2252.

BCL-2/IgH polymerase chain reaction status at the end of induction treatment is not predictive for progression-free survival in relapsed/resistant follicular lymphoma: results of a prospective randomized EORTC 20981 phase III intergroup study. / van Oers, M.H.J.; Tönnissen, E.; van Glabbeke, M. et al.
In: Journal of Clinical Oncology, Vol. 28, No. 13, 2010, p. 2246-2252.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - BCL-2/IgH polymerase chain reaction status at the end of induction treatment is not predictive for progression-free survival in relapsed/resistant follicular lymphoma: results of a prospective randomized EORTC 20981 phase III intergroup study.

AU - van Oers, M.H.J.

AU - Tönnissen, E.

AU - van Glabbeke, M.

AU - Giurgea, L.

AU - Jansen, J.H.

AU - Klasa, R.

AU - Marcus, R.E.

AU - Wolf, M.

AU - Kimby, E.

AU - Vranovsky, A.

AU - Holte, H.

AU - Hagenbeek, A.

AU - van der Reijden, B.A.

PY - 2010

Y1 - 2010

M3 - Article

SN - 0732-183X

VL - 28

SP - 2246

EP - 2252

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 13

ER -

van Oers MHJ, Tönnissen E, van Glabbeke M, Giurgea L, Jansen JH, Klasa R et al. BCL-2/IgH polymerase chain reaction status at the end of induction treatment is not predictive for progression-free survival in relapsed/resistant follicular lymphoma: results of a prospective randomized EORTC 20981 phase III intergroup study. Journal of Clinical Oncology. 2010;28(13):2246-2252.